The Hyderabad-based firm and its subsidiary, Promius Pharma LLC have filed three new drug applications with the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories Ltd said in a statement.
Drug major Dr Reddy's Laboratories on Tuesday said it has filed three new drug applications (NDAs), aimed to be used in the treatments of psoriasis, rosacea, migraine, with the US health regulator.
The Hyderabad-based firm and its subsidiary, Promius Pharma LLC have filed three new drug applications with the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories Ltd said in a statement.
The three NDAs - DFD-01, DFD-09, and DFN-11, come from Dr Reddy's proprietary products group, which is focused on developing and commercialising therapies in dermatology and neurology, it added.
"These products potentially represent new, compelling options for specific segments of patients suffering from Psoriasis, Rosacea and Migraine," Dr Reddy's Executive Vice President of Proprietary Products Raghav Chari said.
They are also the first of a large basket of products targeting conditions predominantly treated by the medical dermatologist and neurologist, he added.
"By focusing exclusively on these two speciality therapeutic areas, we intend to build a leading presence in them over time," Chari said.
Upon approval, the products will be commercialised by Promius Pharma, the company said. Dr Reddy's Laboratories shares today ended at Rs 3,678.45 apiece on the BSE, down 0.02 per cent from previous close.
Dr Reddys Labs stock price
On April 08, 2015, at 09:20 hrs Dr Reddys Laboratories was quoting at Rs 3690.00, up Rs 11.55, or 0.31 percent. The 52-week high of the share was Rs 3706.25 and the 52-week low was Rs 2250.00.
The company's trailing 12-month (TTM) EPS was at Rs 92.70 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 39.81. The latest book value of the company is Rs 547.54 per share. At current value, the price-to-book value of the company is 6.74.
Anda sedang membaca artikel tentang
Dr Reddy's files three new drug applications with USFDA
Dengan url
http://sehatkafein.blogspot.com/2015/04/dr-reddys-files-three-new-drug.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Dr Reddy's files three new drug applications with USFDA
namun jangan lupa untuk meletakkan link
Dr Reddy's files three new drug applications with USFDA
sebagai sumbernya
0 komentar:
Posting Komentar